PMCPA Case Analysis

Over 2,000 real rulings β€” analysed for what they mean to your team. Published every day.

All Cases PMCPA Case of the Week PMCPA Cases

Showing 1914 cases

2020
CASE
AUTH/3356/5/20 Alexion

Alexion: PNH β€œguidance” on hospital website ruled disguised promotion of Soliris (AUTH/3356/5/20)

PNH testing guidance hosted on a hospital website carried Soliris prescribing info and Alexion branding. PMCPA ruled it was promotional, disguised by…

2020
CASE
AUTH/3369/8/20 Pfizer

AUTH/3369/8/20: Complainant v Pfizer β€” Ecalta leavepieces accessible via Google (no breach)

Two withdrawn Ecalta leavepieces with outdated prescribing info were still reachable via direct PDF URLs indexed by Google. Panel found this did…

2019
CASE
AUTH/3286/12/19 Bristol-Myers Squibb Pharmaceuticals

Bristol-Myers Squibb voluntary admission: amended Opdivo/Yervoy promotional article republished online before certification (AUTH/3286/12/19)

BMS admitted a corrected Opdivo/Yervoy promotional article was republished online before certification and final print versions weren’t checked/signed. PMCPA found breaches of…

2019
CASE
Ipsen ⭐ Case of the Week

Ipsen breached ABPI Code after employee’s LinkedIn job title referenced Cabometyx and RCC

An Ipsen employee updated their LinkedIn job title to include β€œCabometyx RCC”. The PMCPA ruled this amounted to promotion of a POM…

2021
CASE
AUTH/3462/1/21 Boehringer Ingelheim

Boehringer Ingelheim: Pradaxa HCP website dosing flowchart found misleading due to poorly signposted renal contraindication (AUTH/3462/1/21)

Pradaxa HCP website dosing flowchart did not clearly flag CrCl <30 mL/min contraindication. Panel said busy HCPs could miss it, making the…

2021
CASE
AUTH/3454/1/21 Sanofi

Sanofi: Toujeo Coach webinar invitation briefing materials (no breach) | AUTH/3454/1/21

Employee complaint about Toujeo Coach webinar invite emails (copy/paste template, tracking sends, alleged reminder emails). Panel found no evidence of non-compliance and…

2021
CASE
AUTH/3475/2/21 Lundbeck

Lundbeck: complaint about alleged promotion of unlicensed Vyepti via SPS website (AUTH/3475/2/21) – No breach

Anonymous health professional alleged Lundbeck updated UK SPS content referencing US launch of Vyepti (not UK-authorised). Panel found no evidence of Lundbeck…

2019
CASE
Allergan

Allergan publicly reprimanded after employees’ LinkedIn β€˜likes’ were ruled promotion of Botox to the public

PMCPA ruled Allergan employees promoted Botox to the public by β€˜liking’ third-party LinkedIn posts using #Botox/#Brotox. Clause 26.1, 9.1 and 2 breached;…

2021
CASE
AUTH/3451/1/21 Teva ⭐ Case of the Week

Teva respiratory websites: missing PI signposting, AE reporting visibility and off-label messaging risk (AUTH/3451/1/21)

Teva’s HCP respiratory webpage lacked prominent PI/AE signposting and omitted PI for two products. A Teva-funded β€œeducational” site was deemed promotional, needed…

2020
CASE
AUTH/3428/11/20 Leo

LEO Pharma: UK employees’ LinkedIn β€˜likes’ brought global posts into scope, triggering certification, PI and pre-licence promotion breaches (AUTH/3428/11/20)

LEO UK staff β€˜liked’ global LinkedIn posts. PMCPA said this proactively disseminated content to UK audiences, making it in-scope. Breaches included uncertified…

2021
CASE
AUTH/3557/9/21 GlaxoSmithKline

AUTH/3557/9/21: Pharmacist v GlaxoSmithKline (Seretide Evohaler price comparison) – No breach

A pharmacist challenged GSK’s β€œover Β£5 cheaper than Fostair at medium dose” claim for Seretide Evohaler (website and journal ad). The PMCPA…

2021
CASE
AUTH/3569/10/21 Pierre Fabre

AUTH/3569/10/21: Pierre Fabre – alleged public promotion of Nerlynx via awards website (No breach)

A member of the public/media alleged Nerlynx was promoted to the public via an open awards website video. Panel found the site…

2021
CASE
AUTH/3534/7/21 Janssen

AUTH/3534/7/21: Astellas v Janssen β€” Zytiga β€œQuality of Life” webpage (misleading comparisons and incomplete context)

Astellas challenged Janssen’s Zytiga QoL webpage. Panel found some claims/graphics misleading (comparator confusion; missing exploratory endpoint context; PHQ-9 implying depression risk), breaching…

2021
CASE
AUTH/3548/7/21 Leo ⭐ Case of the Week

LEO: Senior employee sought confidential competitor discount information from NHS staff (AUTH/3548/7/21)

PMCPA found LEO breached Clauses 9.1 and 2 (2016 Code) after a senior employee sought confidential competitor discount price information from an…

2021
CASE
Aimmune

Aimmune: UK employee β€˜liked’ US LinkedIn post, bringing Palforzia promotion into UK Code scope

A UK-based Aimmune employee β€˜liked’ a US LinkedIn post naming a POM and indication. The Panel said this proactively disseminated promotion to…

Ask questions about any PMCPA case

Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases β€” ask about precedents, clauses, and how they apply to your situation.

⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week β€” free.

Subscribe Free
🎓 AQP Training